1. Home
  2. SCOR vs XLO Comparison

SCOR vs XLO Comparison

Compare SCOR & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCOR
  • XLO
  • Stock Information
  • Founded
  • SCOR 1999
  • XLO 2016
  • Country
  • SCOR United States
  • XLO United States
  • Employees
  • SCOR N/A
  • XLO N/A
  • Industry
  • SCOR Business Services
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCOR Consumer Discretionary
  • XLO Health Care
  • Exchange
  • SCOR Nasdaq
  • XLO Nasdaq
  • Market Cap
  • SCOR 34.6M
  • XLO 35.7M
  • IPO Year
  • SCOR 2007
  • XLO 2021
  • Fundamental
  • Price
  • SCOR $6.41
  • XLO $0.76
  • Analyst Decision
  • SCOR
  • XLO Buy
  • Analyst Count
  • SCOR 0
  • XLO 2
  • Target Price
  • SCOR N/A
  • XLO $3.00
  • AVG Volume (30 Days)
  • SCOR 7.6K
  • XLO 949.7K
  • Earning Date
  • SCOR 11-11-2025
  • XLO 11-06-2025
  • Dividend Yield
  • SCOR N/A
  • XLO N/A
  • EPS Growth
  • SCOR N/A
  • XLO N/A
  • EPS
  • SCOR N/A
  • XLO N/A
  • Revenue
  • SCOR $358,513,000.00
  • XLO $15,001,000.00
  • Revenue This Year
  • SCOR $3.45
  • XLO $982.12
  • Revenue Next Year
  • SCOR $2.59
  • XLO N/A
  • P/E Ratio
  • SCOR N/A
  • XLO N/A
  • Revenue Growth
  • SCOR N/A
  • XLO 536.45
  • 52 Week Low
  • SCOR $4.39
  • XLO $0.62
  • 52 Week High
  • SCOR $8.99
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • SCOR 51.69
  • XLO 53.24
  • Support Level
  • SCOR N/A
  • XLO N/A
  • Resistance Level
  • SCOR $6.92
  • XLO $0.76
  • Average True Range (ATR)
  • SCOR 0.18
  • XLO 0.04
  • MACD
  • SCOR -0.28
  • XLO -0.02
  • Stochastic Oscillator
  • SCOR 91.97
  • XLO 95.14

About SCOR comScore Inc.

comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: